Common, mild effects: Temporary redness, swelling, or discomfort at the injection site
Important safety warning seek urgent medical attention if you experience any of the following: Severe or persistent abdominal pain (which may indicate acute pancreatitis) Right upper quadrant pain, fever, or jaundice (which may indicate gallbladder disease) Reduced urine output, dizziness, or signs of dehydration (which may indicate acute kidney injury) Severe nausea or vomiting preventing adequate fluid intake Signs of a serious allergic reaction (swelling, difficulty breathing, rash) Symptoms of hypoglycaemia such as dizziness, sweating, or confusion These may represent serious adverse effects requiring prompt clinical assessment
Chain-of-custody: record receipt, storage conditions, and access controls for auditability
S., et al., Heavy Metals and Neurodegenerative Diseases: An Observational Study, Biological Trace Element Research 161 (2014): 151160
Concanavalin A selectively reduces desensitization of mammalian neuronal quisqualate receptors
Quality providers offer ongoing consultation as protocols evolve
